Cardiology

The latest edition of EMJ Cardiology is out now, sharing novel case studies and outlining key advances in scientific understanding through reviews and research articles. Featured articles include artificial intelligence in screening for heart disease, idarucizumab in emergent pericardiocentesis, and more. Reviewing the European Society of Cardiology (ESC) 2022 Congress, this issue covers the latest breaking news and updates in the field of cardiology.

This article discussed cigarette smoking as a major risk factor for cardiovascular disease (CVD). Looking through the lens of toxic cigarette smoke constituents, the review described the oxidative stress and inflammatory responses induced following their entry into the bloodstream.

Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).

Speaking at the European Society of Cardiology (ESC) Congress 2021, Gabriel Steg and Kausik Ray discussed the residual risk of recurrent cardiovascular (CV) events that remains despite optimal standards of care for secondary prevention in the 90-day high-risk period after an acute myocardial infarction (AMI).

This article summarises the groundbreaking research and personalised approach to atherosclerotic cardiovascular disease…

EMJ had the pleasure of interviewing leading specialists within the field of cardiology and electrophysiology, Bruno Schwagten, ZNA Middelheim, Antwerp, Belgium, and Yurii Deminskyi…

A leading expert from the field of cardiology and cardiovascular disease provided their perspectives on Phase II data and the design…

CARDIOVASCULAR magnetic resonance (CMR) has emerged as a promising technique for measuring coronary artery disease (CAD) and an alternative…